clemizole
This page covers all clemizole drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Short transient receptor potential channel 4, Histamine H4 receptor, Short transient receptor potential channel 3.
Targets
Phase 2 pipeline (1)
- Lergopenin · Immunology
Clemizole works by binding to the histamine H4 receptor, which is involved in the regulation of immune responses and inflammation.
Patent intelligence
- clemizole patent landscape — aggregated cliff calendar, attackable patents, originator estates